Surgery
Volume 146, Issue 5 , Pages 931-938 , November 2009

Interferon-gamma 874A>T genetic polymorphism is associated with infectious complications following surgery in patients with thoracic esophageal cancer

  • Satoru Motoyama, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • Corresponding Author InformationReprint requests: Satoru Motoyama, MD, PhD, Department of Surgery, Akita University School of Medicine, 1-1-1 Hondo, Akita, Japan 010-8543.
    • ,
  • Masatomo Miura, PhD

      Affiliations

    • Department of Pharmacy, Akita University Hospital, Akita, Japan
    • ,
  • Yudai Hinai, PhD

      Affiliations

    • Department of Pharmacy, Akita University Hospital, Akita, Japan
    • ,
  • Kiyotomi Maruyama, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Shuetsu Usami, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Toshinobu Nakatsu, MD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Hajime Saito, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Yoshihiro Minamiya, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan
    • ,
  • Katsuyuki Murata, MD, PhD

      Affiliations

    • Department of Environmental Health Sciences, Akita University School of Medicine, Akita, Japan
    • ,
  • Toshio Suzuki, PhD

      Affiliations

    • Department of Pharmacy, Akita University Hospital, Akita, Japan
    • ,
  • Jun-ichi Ogawa, MD, PhD

      Affiliations

    • Department of Surgery, Akita University School of Medicine, Akita, Japan

,Accepted 17 April 2009.

References 

  1. Mira JP, Cariou A, Grall F, Delclaux C, Losser MR, Heshmeri F, et al. Association of TNF2, a TNF-alpha promoter polymorphism, with septic shock susceptibility and mortality: a multicenter study. JAMA. 1999;282:561–568
  2. Waterer GW, Quasney MW, Cantor RM, Wunderink RG. Septic shock and respiratory failure in community-acquired pneumonia have different TNF polymorphism associations. Am J Respir Crit Care Med. 2001;163:1599–1604
  3. Read RC, Camp NJ, di Giovine FS, Borrow R, Kaczmarski B, Chaudhary AG, et al. An interleukin-1 genotype is associated with fatal outcome of meningococcal disease. J Infect Dis. 2000;182:1557–1560
  4. Schluter B, Raufhake C, Erren M, Schotte H, Kipp F, Rust S, et al. Effect of the interleukin-6 promoter polymorphism (−174 G/C) on the incidence and outcome of sepsis. Crit Care Med. 2003;30:32–37
  5. Tischendorf JJ, Yagmur E, Scholten D, Vidacek D, Koch A, Winograd AM, et al. The interleukin-6 (IL6)–174 G/C promoter genotype is associated with the presence of septic shock and the ex vivo secretion of IL6. Int J Immunogenet. 2007;34:413–418
  6. Stassen NA, Leslie-Norfleet LA, Robertson AM, Eichenberger MR, Polk HC. Interferon-gamma gene polymorphisms and the development of sepsis in patients with trauma. Surgery. 2002;132:289–292
  7. Reichert S, Machulla HK, Klapproth J, Zimmermann U, Reichert Y, Gläser C, et al. Interferon-gamma and interleukin-12 gene polymorphisms and their relation to aggressive and chronic periodontitis and key periodontal pathogens. J Periodontol. 2008;79:1434–1443
  8. Gallagher PM, Lowe G, Fitzgerald T, Bella A, Greene CM, McElvancy NG, et al. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax. 2003;58:154–156
  9. Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest. 2000;117:1162–1172
  10. Arnalich F, López-Maderuelo D, Codoceo R, Lopez J, Solis-Garrido LM, Capiscol C, et al. Interleukin-1 receptor antagonist gene polymorphism and mortality in patients with severe sepsis. Clin Exp Immunol. 2002;127:331–336
  11. Tashiro T, Yamamori H, Takagi K, Hayashi N, Furukawa K, Nitta H, et al. Changes in immune function following surgery for esophageal carcinoma. Nutrition. 1999;15:760–766
  12. Fujita H, Kakegawa T, Yamana H, Shima I, Toh Y, Tomita Y, et al. Mortality and morbidity rates, postoperative course, quality of life and prognosis after radical lymphadenectomy for esophageal cancer. Ann Surg. 1995;222:654–662
  13. Azim K, McManus R, Brophy K, Ryan A, Kelleher D, Reynolds JV. Genetic polymorphisms and the risk of infection following esophagectomy. Positive association with TNF-alpha gene -308 genotype. Ann Surg. 2007;246:122–128
  14. Nakada TA, Hirasawa H, Oda S, Shiga H, Matsuda K, Nakamura M, et al. Influence of toll-like receptor 4, CD14, tumor necrosis factor, and interleukine-10 gene polymorphisms on clinical outcome in Japanese critically ill patients. J Surg Res. 2005;129:322–328
  15. Day CP, Grove J, Daly AK, Stewart MW, Avery PJ, Walker M. Tumour necrosis factor-alpha gene promoter polymorphism and decreased insulin resistance. Diabetologia. 1998;41:430–434
  16. Skoog T, van't Hooft FM, Kallin B, Jovinge S, Boquist S, Nilsson J, et al. A common functional polymorphism (C–>A substitution at position -863) in the promoter region of the tumour necrosis factor-alpha (TNF-alpha) gene associated with reduced circulating levels of TNF-alpha. Hum Mol Genet. 1999;8:1443–1449
  17. Kim TG, Kim HY, Lee SH, Cho CS, Park SH, Choi HB, et al. Systemic lupus erythematosus with nephritis is strongly associated with the TNFB∗2 homozygote in the Korean population. Hum Immunol. 1996;46:10–17
  18. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol. 2000;61:863–866
  19. Shu XO, Gao YT, Cai Q, Pierce L, Cai H, Ruan ZX, et al. Genetic polymorphisms in the TGF-beta 1 gene and breast cancer survival: a report from the Shanghai Breast Cancer Study. Cancer Res. 2004;64:836–839
  20. Graziano F, Ruzzo A, Santini D, Humar B, Tonini G, Catalano V, et al. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol. 2005;23:2339–2345
  21. Lehtimäki T, Laaksonen R, Janatuinen T, Vesalainen R, Nuutila P, Mattila K, et al. Interleukin-1B genotype modulates the improvement of coronary artery reactivity by lipid-lowering therapy with pravastatin: a placebo-controlled positron emission tomography study in young healthy men. Pharmacogenetics. 2003;13:633–639
  22. Graziano F, Ruzzo A, Santini D, Humar B, Tonini G, Catalano V, et al. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol. 2005;23:2339–2345
  23. Ross OA, Curran MD, Meenagh A, Williams F, Barnett YA, Middleton D, et al. Study of age-association with cytokine gene polymorphisms in an aged Irish population. Mech Ageing Dev. 2003;124:199–206
  24. Noguchi E, Shibasaki M, Arinami T, Takeda K, Yokouchi Y, Kawashima T, et al. Association of asthma and the interleukin-4 promoter gene in Japanese. Clin Exp Allergy. 1998;28:449–453
  25. Buraczynska M, Jozwiak L, Ksiazek P, Borowicz E, Mierzicki P. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl Res. 2007;150:101–105
  26. Wolford JK, Colligan PB, Gruber JD, Bogardus C. Variants in the interleukin 6 receptor gene are associated with obesity in Pima Indians. Mol Genet Metab. 2003;80:338–343
  27. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology. 1999;30:526–530
  28. Hall MA, McGlinn E, Coakley G, Fisher SA, Boki K, Middleton D. Genetic polymorphism of IL-12 p40 gene in immune-mediated disease. Genes Immun. 2000;1:219–224
  29. Abraham E, Matthay MA, Dinarello CA, Vincent JL, Cohen J, Opal SM, et al. Consensus conference definitions for sepsis, septic shock, acute lung injury, and acute respiratory distress syndrome: time for a reevaluation. Crit Care Med. 2000;28:232–235
  30. Filipe-Santos O, Bustamante J, Chapgier A, Vogt G, de Beaucoudrey L, Feinberg J, et al. Inborn errors of IL-12/23- and IFN-gamma-mediated immunity: molecular, cellular, and clinical features. Semin Immunol. 2006;18:347–361
  31. Eleftheriadis T, Voyatzi S, Antoniadi G, Kartsios C, Liakopoulos V, Paraskevopoulos P, et al. Major histocompatibility complex class I restricted T-cell autoreactivity in human peripheral blood mononuclear cells. Cell Immunol. 2006;240:62–67
  32. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-gamma. Annu Rev Immunol. 1997;15:749–795
  33. Schoenborn JR, Wilson CB. Regulation of interferon-γ during innate and adaptive immune responses. Adv Immunol. 2007;96:41–101
  34. Bekpen C, Hunn JP, Rohde C, Parvanova I, Guethlein L, Dunn DM, et al. The interferon-inducible p47 (IRG) GTPases in vertebrates: loss of the cell autonomous resistance mechanism in the human lineage. Genome Biol. 2005;6:R92
  35. Martens S, Howard J. The interferon-inducible GTPases. Annu Rev Cell Dev Biol. 2006;22:559–589
  36. MacMicking JD. Immune control of phagosomal bacteria by p47 GTPases. Curr Opin Microbiol. 2005;8:74–82
  37. Taylor GA, Feng CG, Sher A. Control of IFN-γ-mediated host resistance to intracellular pathogens by immunity-related GTPases (p47 GTPases). Microbes Infect. 2007;9:1644–1651
  38. Schena FP, Cerullo G, Torres DD, Scolari F, Foramitti M, Amoroso A, et al. Role of interferon-gamma gene polymorphisms in susceptibility to IgA nephropathy: a family-based association study. Eur J Hum Genet. 2006;14:488–496
  39. Hoffmann SC, Stanley EM, Darrin Cox E, Craighead N, DiMercurio BS, Koziol DE, et al. Association of cytokine polymorphic inheritance and in vitro cytokine production in anti-CD3/CD28-stimulated peripheral blood lymphocytes. Transplantation. 2001;72:1444–1450
  40. Daly JM, Weintraub FN, Shou J, Rosato EF, Lucia M. Enteral nutrition during multimodality therapy in upper gastrointestinal cancer patients. Ann Surg. 1995;221:327–338
  41. Kudsk KA, Tolley EA, DeWitt RC, Janu PG, Blackwell AP, Yeary S, et al. Preoperative albumin and surgical site identify surgical risk for major postoperative complications. JPEN J Parenter Enteral Nutr. 2003;27:1–9

PII: S0039-6060(09)00359-6

doi: 10.1016/j.surg.2009.04.034

Surgery
Volume 146, Issue 5 , Pages 931-938 , November 2009

Article Tools